Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia

被引：7

作者：

Das, Prabodh ^{[1
]}

Carcao, Manuel ^{[1
]}

Hitzler, Johann ^{[1
]}

机构：

[1] Univ Toronto, Div Hematol Oncol, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada

来源：

PEDIATRIC BLOOD & CANCER | 2006年 / 47卷 / 02期

关键词：

hemorrhage; lumbar; pediatric acute leukemia; prophylaxis; puncture; recombinant activated factor VII;

D O I：

10.1002/pbc.20467

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The persistence of abnormal coagulation test results after standard treatment with fresh frozen plasma (FFP) poses significant problems in children with acute leukemia requiring a diagnostic lumbar puncture and intrathecal chemotherapy. We report the prophylactic use of a single dose of 90 mu g/kg recombinant activated factor VII (rFVIIa) in three children and the rapid correction of abnormal coagulation test results previously not corrected by FFP. Administration of rFVIIa was useful in avoiding a delay of diagnostic lumbar punctures and intrathecal chemotherapy. Hemorrhagic complications and adverse effects of rFVIIa were not observed. Prospective evaluation of this indication and dose appears warranted.

引用

页码：206 / 209

页数：4

共 40 条

[21] Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies [J].

Mariani, G ;

Testa, MG ;

Di Paolantonio, T ;

Bech, RM ;

Hedner, U .

VOX SANGUINIS, 1999, 77 (03) :131-136

[22] The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics - A systematic review [J].

Mathew, P .

THROMBOSIS AND HAEMOSTASIS, 2004, 92 (04) :738-746

[23] Novel applications of recombinant factor VIIa for the management of pediatric coagulopathic diseases [J].

Mathew, P ;

Winter, SS ;

Frost, JD ;

Hanrahan, J ;

Schwartz, M ;

Jones, JE .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (06) :499-502

[24] Coagulation system and platelets are fully activated in uncomplicated sepsis [J].

Mavrommatis, AC ;

Theodoridis, T ;

Orfanidou, A ;

Roussos, C ;

Christopoulou-Kokkinou, V ;

Zakynthinos, S .

CRITICAL CARE MEDICINE, 2000, 28 (02) :451-457

[25]

Monroe DM, 1998, BLOOD COAGUL FIBRIN, V9, pS15

[26] Recombinant activated factor VII for cerebral injury-induced coagulopathy in pediatric patients - Report of three cases and review of the literature [J].

Morenski, JD ;

Tobias, JD ;

Jimenez, DF .

JOURNAL OF NEUROSURGERY, 2003, 98 (03) :611-616

[27] Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients [J].

Park, P ;

Fewel, ME ;

Garton, HJ ;

Thompson, BG ;

Hoff, JT .

NEUROSURGERY, 2003, 53 (01) :34-38

[28] Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia [J].

Poon, MC ;

Demers, C ;

Jobin, F ;

Wu, JWY .

BLOOD, 1999, 94 (11) :3951-3953

[29]

RAMSAY NKC, 1977, CANCER, V40, P1398, DOI 10.1002/1097-0142(197710)40:4<1398::AID-CNCR2820400406>3.0.CO

[30]

2-#

← 1 2 3 4 →